Through subtractive genomics approach between pathogenic bacteria and human host, I have deduced 11 proteins, which can be potent drug targets (non homologous to host, essential to pathogen and pathway mapping done). How can I further predict and confirm through experimental approaches best of the drug targets that can be novel?
More Sandeep Telkar's questions See All
Similar questions and discussions